Varo Victoria

Thyngs is a physical to digital contactless marketing and payments platform for charities and brand marketers. It’s built on the simple idea that real-world interactions have a greater, longer-lasting, and more memorable impact. Using smartphone technology like QR and NFC we turn offline marketing assets into high converting digital experiences. Charities and brand marketers use Thyngs to take touch-free payments, reward customer loyalty, and fundraise via campaigns, competitions and promotions. WHAT EXPERIENCE WILL YOU CREATE? - How about a scratch and win game? - Or a fun selfie experience. - Collect touch free, cashless donations via your charity mascot. - Or enable frictionless ordering and payments for your restaurant. - You could digitise your customer loyalty cards. - Or simply deliver personalised content based on context, time, and place. EVERYTHING YOU NEED IN ONE PLACE. Cost-effectively enhance all offline marketing assets such as points of sale, packaging, charity buckets and mascots. Then create, deploy and manage your offline to online experiences using our all-in-one platform. Use interaction and conversion data to improve existing campaigns and inform future projects. - EASY & FAST DEPLOYMENT: No bespoke technology or skills needed - MOBILE OPTIMISED: Choose from our templated experiences or create your own - HIGH CONVERTING: Frictionless user experiences and payment journeys - REAL-TIME INSIGHT: Gain new insight into offline marketing with analytics DO MORE WITH THYNGS. Contactless technology can help solve the fundraising crisis for charities, and to give people the confidence to shop on the high street, eat out, and access services safely. The good news is that this technology is available in every smartphone and we’ve built a straightforward, low-cost solution to create, deploy and manage these services. Visit our website: www.thyngs.net Give us a call for a platform demo: 0333 335 0490 Festive Demo: https://thyg.uk/AUU45356

DNA is the blueprint to what makes you who you are. It is the most valuable piece of personal information an individual will ever own. It is an appreciating asset that will continue to increase in value as genetic research continues to unlock mysteries in DNA over time. However, as soon as individuals send their saliva to a sequencing facility and their DNA is read, they relinquish all control over their data. Organisations that hold this data currently do not have the technology to safeguard it from data hacks/breaches and many legally share DNA data in plain text to third parties in multi-million dollar deals. This means that individuals not only are excluded from taking part in any value their DNA may hold but lose ownership and privacy of highly sensitive DNA data. We at Genomes.io believe individuals should be able to own, control access to and benefit from their most sensitive and valuable personal asset, their DNA. We are building a secure DNA sequencing, storage and sharing technology using state-of-the-art encryption and blockchain technologies to provide users with control over their whole genome sequence. This allows users to control access to segments of their genome in a repeat consent model to trusted professionals and accredited researchers in a secure, private and anonymous manner. Our platform acts as genomic data aggregator that provides research organisations with a more efficient genomic data acquisition model. However, we do so in a more equitable model in which individuals own, control and get paid for the data they wish to share. We aim to securely sequence and store 1 billion individual’s genomes in our DNA data bank and become the world’s largest, most secure and trusted genomic and health data marketplace to power the personalised medicine revolution. Genomes.io - Invest in Future You.

Arival is a licensed and regulated digital bank geared towards a new generation of global businesses and startups. Banks are old. Were not.™

We are a health data and insights business focused on metabolic disease. We are building the worlds most comprehensive and rich metabolic data set. From this we develop algorithms that enable earlier identification of complications and earlier interventions.

Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, and is already available on the European market. We offer a wide range of services based on 𝘪𝘯 𝘷𝘪𝘷𝘰 and 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 essays. Leading clients in more than 30 countries trust us with their custom biomarker projects and solutions. We specialize in the application of our assays in three fundamental fields: diagnosis and prognosis in oncology, personalized and preventive medicine, as well as in the B2B/CRO industry. At Life Length, we are firmly committed to the development and implementation of an effective quality management system that ensures excellence in our services provided. 𝐎𝐮𝐫 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧𝐬: • ISO 15189 • CLIA • AEMPS • ISO 13485 • State of California, Rhode Island, Maryland and Pennsylvania licences Our mission at Life Length is to improve health and prolong peoples lives by leveraging our cutting-edge technologies and the exceptional talent of our team.

Elemental turns an international food waste problem into valuable sustainable products. With impressive nutritional, economic and environmental benefits, our products result from a fully circular recovery process with zero waste. We are an innovative process technology Devon based company that holds international patents and intellectual property. The Elemental technology reduces the economic cost and environmental impact of food production by preventing waste through the conversion of discarded organic material into sustainable protein-rich food ingredients, edible fats and a regenerative phosphate-rich organo-mineral fertiliser.

Stablepharma Ltd is an innovative biopharmaceutical company developing a pipeline of fridge-free vaccine and pharmaceutical products. Stablepharma was founded with a simple purpose; to use its novel technology to dramatically improve health outcomes for those adults and children most at risk of death and disability caused by vaccine preventable diseases. StablevaX is an adaptable fridge-free technology which offers a greatly extended shelf-life, reduces vaccine wastage and CO2 emissions of the global cold-chain. The WHO estimate that approximately 50% of all vaccines manufactured are wasted due to failures in the global cold chain (distribution and storage of vaccines). Stablepharma aims to ensure that a proportion of vital vaccines and pharmaceutical products can be removed from the refrigerated cold chain and stored for months or even years at room temperature. Stablepharma is developing the worlds first fridge-free vaccine, SPVX02 for Tetanus diphtheria, a pharmaceutical product for the prevention of Tetanus and Diphtheria.

Manufacture 2030 provides global corporations with the certainty they need to hit their Scope 3 emissions reduction targets, using our unique platform, to measure, manage and improve the performance of each individual site in their manufacturing supply chain. Here are just a few ways in which we do this: Site level - We measure in detail, manage to target and accelerate improvement to close the gaps at the specific, individual sites that supply you. Forward visibility - Unlike other platforms, we give you more than just visibility of your supply chain footprint. It lets you see whether individual supplier sites are tracking to your target, where the gaps are, and how to help close them. Tailored action plans - Uniquely, each supplier site can use our platforms database of 500+ detailed best practices and participate in our capacity building programs to implement an action plan to close their specific gap to your target. Improvement at scale - Our cloud-based platform makes it cost-effective and straightforward for thousands of suppliers to collaborate with you to reach your Scope 3 targets. We’d love to tell you more about Manufacture 2030 and how our platform and service can make hitting your Scope 3 carbon reduction target more certain. Please get in touch with us for more information or if you’d like an informal chat to see how we can help you. e: info@manufacture2030.com t: +44 (0)1865 597640

Small Robot Co is making farming more financially and environmentally sustainable. We help farmers to understand and optimise care for every plant in every field. By providing field-scale actionable insights at a plant level we can optimise spray technology to reduce chemicals and waste. Small is good.

www.gunnadrinks.com Proud makers of Gunna soft drinks. An award winning range of intriguingly refreshing soft drinks, with true character and style. Inspired by traditional soft drinks recipes from around the world. Less than 5% sugar, but no compromise on taste.

A beautifully simple way to sell your images, used by over 500,000 photographers worldwide.

Nanusens is pioneering sensors built inside CMOS. Nanusens patent-pending technology shrinks MEMS sensors and builds nano-scale sensors (NEMS – Nano Electro Mechanical Systems) along with the control electronics using standard CMOS processes. This creates single chip solutions that are up to ten times smaller than the equivalent multi-package MEMS. The freed-up space can be used for larger batteries for longer operational life battery or additional features. Many different sensors can be built into the same tiny chip to enhance the user experience and differentiate products without taking up more space. Its expertise and pending patents place it as the uncontested leader in this technology that will revolutionise the next generation of sensors. Nanusens also uses its innovative technology to create DTCs (Digital Tuneable Capacitors) or RF switches for 5G smartphones. Again, by shrinking these MEMS into the CMOS layers along with the control electronics on the same die, Nanusens saves space. Founded in 2014 by Dr. Josep Montanyà, Dr. Daniel Fernández and Dr. Marc Llamas, Nanusens is headquartered in London, England with Research and Development offices in Barcelona, Spain and Shenzen, China. It leverages the research and expertise developed by the founders’ previous company, Baolab Microsystems. Nanusens is VC funded by Inveready (www.inveready.com/venture-capital/), Caixa Capital Risc (www.caixacapitalrisc.es/en/) and Dieco Capital (www.dieco-capital.com), and crowdfunding via Crowdcube.

We are a business born out of a global environmental crisis. We are convinced that a combination of technology, innovation and determination can make a true difference in the world we live in today. We live and breathe the reduce, reuse, recycle mantra and we believe that plastic is a great material and an integral part of the solution to reducing our carbon footprint. Our mission is to accelerate the evolution of plastic into a more sustainable material through innovation and technical excellence. Our vision is to be a global force driving positive change towards a sustainable future. CAREERS AT RECYCLING TECHNOLOGIES: Were looking for people who think differently. We want people that like to get involved and are looking to make a real impact for the future. We have an exceptional team of vibrant personalities and international backgrounds. If you want to inspire, be inspired and work in a highly innovative environment. Watch our videos at www.recyclingtechnologies.co.uk/careers

Vervs mission is clear: to eliminate the 4% of global energy waste from inefficient heating and cooling systems while offering AI-driven predictive maintenance. With 13 global patents, Verv stands as a pioneer in this field, serving a diverse clientele of sustainability leaders and engineering heads. Verv is at the forefront of climate control innovation and supporting the built environment in making its mark in driving efficiency and achieving Net Zero targets.

For hospitality operators who need to grow, Vita Mojo is the industry expert that uncovers challenges and supports ambitions through our unique blend of service excellence, flexible solution and tailored consultancy. Our approach is rooted in real-world restaurant experience and refined at leading hospitality brands, including Subway, YO!, LEON and GAILs.

Thyngs is a physical to digital contactless marketing and payments platform for charities and brand marketers. It’s built on the simple idea that real-world interactions have a greater, longer-lasting, and more memorable impact. Using smartphone technology like QR and NFC we turn offline marketing assets into high converting digital experiences. Charities and brand marketers use Thyngs to take touch-free payments, reward customer loyalty, and fundraise via campaigns, competitions and promotions. WHAT EXPERIENCE WILL YOU CREATE? - How about a scratch and win game? - Or a fun selfie experience. - Collect touch free, cashless donations via your charity mascot. - Or enable frictionless ordering and payments for your restaurant. - You could digitise your customer loyalty cards. - Or simply deliver personalised content based on context, time, and place. EVERYTHING YOU NEED IN ONE PLACE. Cost-effectively enhance all offline marketing assets such as points of sale, packaging, charity buckets and mascots. Then create, deploy and manage your offline to online experiences using our all-in-one platform. Use interaction and conversion data to improve existing campaigns and inform future projects. - EASY & FAST DEPLOYMENT: No bespoke technology or skills needed - MOBILE OPTIMISED: Choose from our templated experiences or create your own - HIGH CONVERTING: Frictionless user experiences and payment journeys - REAL-TIME INSIGHT: Gain new insight into offline marketing with analytics DO MORE WITH THYNGS. Contactless technology can help solve the fundraising crisis for charities, and to give people the confidence to shop on the high street, eat out, and access services safely. The good news is that this technology is available in every smartphone and we’ve built a straightforward, low-cost solution to create, deploy and manage these services. Visit our website: www.thyngs.net Give us a call for a platform demo: 0333 335 0490 Festive Demo: https://thyg.uk/AUU45356

DNA is the blueprint to what makes you who you are. It is the most valuable piece of personal information an individual will ever own. It is an appreciating asset that will continue to increase in value as genetic research continues to unlock mysteries in DNA over time. However, as soon as individuals send their saliva to a sequencing facility and their DNA is read, they relinquish all control over their data. Organisations that hold this data currently do not have the technology to safeguard it from data hacks/breaches and many legally share DNA data in plain text to third parties in multi-million dollar deals. This means that individuals not only are excluded from taking part in any value their DNA may hold but lose ownership and privacy of highly sensitive DNA data. We at Genomes.io believe individuals should be able to own, control access to and benefit from their most sensitive and valuable personal asset, their DNA. We are building a secure DNA sequencing, storage and sharing technology using state-of-the-art encryption and blockchain technologies to provide users with control over their whole genome sequence. This allows users to control access to segments of their genome in a repeat consent model to trusted professionals and accredited researchers in a secure, private and anonymous manner. Our platform acts as genomic data aggregator that provides research organisations with a more efficient genomic data acquisition model. However, we do so in a more equitable model in which individuals own, control and get paid for the data they wish to share. We aim to securely sequence and store 1 billion individual’s genomes in our DNA data bank and become the world’s largest, most secure and trusted genomic and health data marketplace to power the personalised medicine revolution. Genomes.io - Invest in Future You.

Arival is a licensed and regulated digital bank geared towards a new generation of global businesses and startups. Banks are old. Were not.™

We are a health data and insights business focused on metabolic disease. We are building the worlds most comprehensive and rich metabolic data set. From this we develop algorithms that enable earlier identification of complications and earlier interventions.

Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, and is already available on the European market. We offer a wide range of services based on 𝘪𝘯 𝘷𝘪𝘷𝘰 and 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 essays. Leading clients in more than 30 countries trust us with their custom biomarker projects and solutions. We specialize in the application of our assays in three fundamental fields: diagnosis and prognosis in oncology, personalized and preventive medicine, as well as in the B2B/CRO industry. At Life Length, we are firmly committed to the development and implementation of an effective quality management system that ensures excellence in our services provided. 𝐎𝐮𝐫 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧𝐬: • ISO 15189 • CLIA • AEMPS • ISO 13485 • State of California, Rhode Island, Maryland and Pennsylvania licences Our mission at Life Length is to improve health and prolong peoples lives by leveraging our cutting-edge technologies and the exceptional talent of our team.